Press Release: COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
Cannabis Law Report
JULY 6, 2021
This collaboration is intended to include research into COMP360 psilocybin therapy and other novel therapies that may be developed by COMPASS in areas of unmet need such as depression, post-traumatic stress disorder (PTSD) and anorexia. London, UK – 5 July 2021. George Goldsmith, CEO and Co?founder,
Let's personalize your content